Gavriely Noam, Rasanen Jukka O, Saar Sharon Abadi, Lamhaut Lionel, Hutin Alice, Lidouren Fanny, Abi Zeid Daou Yara, Tissier Renaud
Technion, Israel Institute of Technology (ret), Haifa, Israel.
Oneg HaKarmel Ltd., Tirat Carmel, Israel.
Resusc Plus. 2024 Jun 12;19:100681. doi: 10.1016/j.resplu.2024.100681. eCollection 2024 Sep.
The cognitive outcome of CPR is poor. This study aims to evaluate if enhancing blood flow to the brain and oxygen dissociation from the hemoglobin improve cerebral O transport during CPR in cardiac arrest swine.
Standard swine-CPR model of induced VF and recovery was treated with an auto-transfusion tourniquet (A-TT®; HemaShock® (HS) Oneg HaKarmel Ltd. Israel) and ventilation with a novel mixture of 30% Oxygen, 5% CO, and 65% Argon (COXAR™). Five swine received the study treatment and 5 controls standard therapy. Animals were anesthetized, ventilated, and instrumented for blood draws and pressure measurements. Five minutes of no-CPR arrest were followed by 10 min of mechanical CPR with and without COXAR-HS™ enhancement followed by defibrillation and 45 min post ROSC follow-up.
All 5 COXAR-HS™ animals were resuscitated successfully as opposed to 3 of the control animals. Systolic ( < 0.05), and diastolic ( < 0.01) blood pressures, and coronary ( < 0.001) and cerebral ( < 0.05) perfusion pressures were higher in the COXAR-HS™ group after ROSC, as well as cerebral flow and O provided to the brain ( < 0.05). Blood pressure maintenance after ROSC required much higher doses of norepinephrine in the 3 resuscitated control animals vs. the 5 COXAR-HS™ animals ( < 0.05). jugular vein PO and SO exceeded 50 mmHg and 50%, respectively with COXAR-HS™.
In this pilot experimental study, COXAR-HS™ was associated with higher diastolic blood pressure and coronary perfusion pressure with lower need of vasopressors after ROSC without significant differences prior to ROSC. The higher PO and SO suggest enhanced O provision to the brain mitochondria, while limb compression by the HS counteracts the vasodilatory effect of the CO. Further studies are needed to explore and validate the COXAR-HS™ effects on actual post-ROSC brain functionality.
心肺复苏(CPR)的认知结局较差。本研究旨在评估在心脏骤停猪的CPR过程中,增加脑血流量以及改善血红蛋白的氧解离是否能提高脑氧输送。
采用诱导室颤和复苏的标准猪CPR模型,使用自动输血止血带(A-TT®;以色列Oneg HaKarmel Ltd.公司的HemaShock®(HS)),并采用含30%氧气、5%二氧化碳和65%氩气的新型混合气体(COXAR™)进行通气。5只猪接受研究治疗,5只作为对照接受标准治疗。动物麻醉后进行通气,并安装用于采血和压力测量的仪器。先进行5分钟无CPR的心脏骤停,然后进行10分钟有或无COXAR-HS™增强的机械CPR,随后进行除颤,并在自主循环恢复(ROSC)后进行45分钟的随访。
所有5只接受COXAR-HS™治疗的动物均成功复苏,而对照组动物仅有3只成功复苏。ROSC后,COXAR-HS™组的收缩压(<0.05)、舒张压(<0.01)、冠状动脉灌注压(<0.001)和脑灌注压(<0.05)均较高,脑血流量和输送至脑的氧量也较高(<0.05)。与5只接受COXAR-HS™治疗的动物相比,3只复苏的对照动物在ROSC后维持血压需要更高剂量的去甲肾上腺素(<0.05)。使用COXAR-HS™时,颈静脉血氧分压(PO)和氧饱和度(SO)分别超过50 mmHg和50%。
在这项初步实验研究中,COXAR-HS™与较高的舒张压和冠状动脉灌注压相关,ROSC后对血管升压药的需求较低,ROSC前无显著差异。较高的PO和SO表明向脑线粒体提供的氧量增加,而HS对肢体的压迫抵消了二氧化碳的血管舒张作用。需要进一步研究来探索和验证COXAR-HS™对ROSC后脑实际功能的影响。